Stephanie Fine
Surgery · Albuquerque, NMNPI 1922008622
Payments from drug & device makers
Across 20 payments — averaging $44.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$212
- Gilead$121
- Stemline Therapeutics Inc.$120
- Tactile Systems Technology Inc$109
- AstraZeneca$67
- Seagen Inc.$39
- plus $228 from 10 others
What the payments were for
- Food & beverage$897100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $212 |
| Gilead | 1 | $121 |
| Stemline Therapeutics Inc. | 1 | $120 |
| Tactile Systems Technology Inc | 1 | $109 |
| AstraZeneca | 2 | $67 |
| Seagen Inc. | 1 | $39 |
| Incyte Corporation | 2 | $34 |
| Novartis | 1 | $32 |
| Johnson & Johnson(2 entities) | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Exelixis Inc. | 1 | $23 |
| Merit Medical Systems Inc | 1 | $19 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
| Beone Medicines USA, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Tempus AI, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$122
- Trodelvy$121
- Orserdu$120
- Flexitouch Plus$109
- Nimbl$109
How this compares
$897 in reported general payments places this provider in the 40th percentile of 162 surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in Albuquerque
- Mario LeybaAlbuquerque$1.3M
- Michael BleaAlbuquerque$481K
- David HoangAlbuquerque$264K
- Erica McBrideAlbuquerque$95K
- Gregory BorahAlbuquerque$77K
- Edward AuyangAlbuquerque$70K
- Jacquelyn BrandenburgAlbuquerque$60K
- Jay ZhuAlbuquerque$57K
- Brian HoltAlbuquerque$48K
- Christopher DominguezAlbuquerque$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.